Video

Dr. Weiss on the Role of Immunotherapy in Head and Neck Cancer

Author(s):

Jared Weiss, MD

In Partnership With:

Jared Weiss, MD, assistant professor, UNC Lineberger Comprehensive Cancer Center, discusses the role of immunotherapy in head and neck cancer.

Jared Weiss, MD, assistant professor, UNC Lineberger Comprehensive Cancer Center, discusses the role of immunotherapy in head and neck cancer.

Related Videos
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Michael R. Grunwald, MD, FACP
Peter Forsyth, MD
John N. Allan, MD
Dr Dorritie on the Clinical Implications of the 5-Year Follow-Up Data From CAPTIVATE in CLL/SLL
Minoo Battiwalla, MD, MS
Kathleen N. Moore, MD, MS
Related Content
Toripalimab Plus Chemo for Nasopharyngeal Carcinoma and ESCC | Image Credit: © Cornflakesei - stock.adobe.com
November 18th 2024

Toripalimab Plus Chemo Approved in UK for Frontline Nasopharyngeal Carcinoma and ESCC

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

lertsakwiman– stock.adobe.com
November 12th 2024

Selumetinib Boosts ORR in NF1 With Inoperable Plexiform Neurofibroma

Yara Abdou, MD
December 7th 2023

Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer

ESMO 2024
November 1st 2024

The Top News From ESMO 2024: A Variety of Data Inform Solid Tumor Landscapes

Jianjun Zou, MD, PhD
October 15th 2024

Toripalimab Wins Approval in India and Hong Kong for Recurrent/Metastatic Nasopharyngeal Carcinoma